virtual clinical trials market

Global Virtual Clinical Trials Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

  • Published Date: 2021-01-17
  • Report ID: 39061
  • Pages: 117
  • Format: prudent report format

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Virtual Clinical Trials market in this environment.

In terms of revenue, this research report indicated that the global Virtual Clinical Trials market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Virtual Clinical Trials industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The ICON Plc aims at producing XX Virtual Clinical Trials in 2020, with XX % production to take place in global market, LEO Innovation Lab accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Virtual Clinical Trials Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Virtual Clinical Trials Market
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
...
Major Type of Virtual Clinical Trials Covered in Prudent Markets report:
Interventional Trials
Observational Trials
Expanded Access Trials
Application Segments Covered in Prudent Markets Market
Oncology
Cardiovascular Disease
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Virtual Clinical Trials Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Interventional Trials -Product Introduction and Major Manufacturers
1.1.2 Observational Trials -Product Introduction and Major Manufacturers
1.1.3 Expanded Access Trials -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Virtual Clinical Trials Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Virtual Clinical Trials Market
3.1.1 Top Companies leading Virtual Clinical Trials Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Virtual Clinical Trials Market
3.2.1 Top Companies leading Virtual Clinical Trials Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Virtual Clinical Trials Market
3.3.1 Top Companies leading Virtual Clinical Trials Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Virtual Clinical Trials Market
3.4.1 Top Companies leading Virtual Clinical Trials Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Virtual Clinical Trials Market
3.5.1 Top Companies leading Virtual Clinical Trials Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Virtual Clinical Trials Market
3.6.1 Top Companies leading Virtual Clinical Trials Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Virtual Clinical Trials Market
3.7.1 Top Companies leading Virtual Clinical Trials Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Virtual Clinical Trials Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Virtual Clinical Trials Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Virtual Clinical Trials Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Virtual Clinical Trials Sales and Growth Rate (2021-2026)
5.2 Global Virtual Clinical Trials Sales Value and Growth Rate (2021-2026)

6 Virtual Clinical Trials Competitive Analysis
6.1 ICON Plc
6.1.1 ICON Plc Company Profiles
6.1.2 ICON Plc Product Introduction
6.1.3 ICON Plc Virtual Clinical Trials Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 LEO Innovation Lab
6.2.1 LEO Innovation Lab Company Profiles
6.2.2 LEO Innovation Lab Product Introduction
6.2.3 LEO Innovation Lab Virtual Clinical Trials Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Science 37
6.3.1 Science 37 Company Profiles
6.3.2 Science 37 Product Introduction
6.3.3 Science 37 Virtual Clinical Trials Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 PRA Health Sciences
6.4.1 PRA Health Sciences Company Profiles
6.4.2 PRA Health Sciences Product Introduction
6.4.3 PRA Health Sciences Virtual Clinical Trials Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Clinical Ink
6.5.1 Clinical Ink Company Profiles
6.5.2 Clinical Ink Product Introduction
6.5.3 Clinical Ink Virtual Clinical Trials Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Parexel
6.6.1 Parexel Company Profiles
6.6.2 Parexel Product Introduction
6.6.3 Parexel Virtual Clinical Trials Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Medable
6.7.1 Medable Company Profiles
6.7.2 Medable Product Introduction
6.7.3 Medable Virtual Clinical Trials Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Oracle
6.8.1 Oracle Company Profiles
6.8.2 Oracle Product Introduction
6.8.3 Oracle Virtual Clinical Trials Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 CRF Health
6.9.1 CRF Health Company Profiles
6.9.2 CRF Health Product Introduction
6.9.3 CRF Health Virtual Clinical Trials Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Medidata
6.10.1 Medidata Company Profiles
6.10.2 Medidata Product Introduction
6.10.3 Medidata Virtual Clinical Trials Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Covance
6.12 IQVIA
7 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.